Northwire Canada EditionFriday, October 16, 2026
Northwire
⌕
GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8% GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8%
M&A / Property

Canopy Growth Completes Acquisition of MTL Cannabis Creating Canada's Leading Medical Cannabis Business By Revenue

WEED · Price

Executive Summary

  • Canopy Growth completed the acquisition of 100% of MTL Cannabis, issuing ~41.2 million Canopy shares and paying approximately C$18.5 million cash to MTL shareholders.
  • The deal creates Canada’s leading medical‑cannabis platform, adds high‑quality flower capacity, expands Québec presence, and is expected to generate ≈C$10 million of run‑rate synergies within 18 months and support a path to positive adjusted EBITDA by FY2027.
  • Key MTL executives (including COO Mike Perron and co‑founders Richard & Michel Clément) join Canopy’s leadership team, strengthening operational depth and integration capabilities.

Key Details

  • Consideration: Each MTL share exchanged for 0.32 Canopy common share + C$0.144 cash.
  • Shares Issued: ~41.2 million Canopy shares to MTL shareholders; additional 2,956,391 shares issued to former MC shareholders (subject to an 18‑month transfer restriction).
  • Cash Paid: Approximately C$18.5 million paid to Odyssey Trust Company in trust for MTL shareholders.
  • De‑listing: MTL shares expected to be de‑listed from the Canadian Securities Exchange around 2026‑03‑16.
  • Leadership Additions:
  • Mike Perron – Chief Operating Officer (formerly CEO of MTL)
  • Richard Clément & Michel Clément – Strategic Advisors
  • Additional senior staff listed in release (e.g., Chrissy McHardy, Andrew Bevan).
  • Strategic Benefits:
  • Strengthens Canopy’s medical‑cannabis market‑share leadership in Canada.
  • Expands high‑quality flower supply for Canadian and international (including European) markets.
  • Deepens Québec footprint via MTL cultivation facilities and product portfolio.
  • Adds profitable, cash‑generating operations to accelerate margin improvement and EBITDA growth.
  • Synergies: Anticipated run‑rate synergies of ~C$10 million within 18 months post‑integration.
  • Advisors & Counsel:
  • Canaccord Genuity – exclusive financial advisor to Canopy.
  • Cassels Brock & Blackwell LLP / Paul Hastings LLP – legal counsel to Canopy.
  • Haywood Securities – exclusive financial advisor to MTL’s special committee (provided fairness opinion).
  • Farris LLP – legal counsel to MTL.

Notable Quotes

  • “The acquisition of MTL is a defining step forward in strengthening Canopy Growth’s core Canadian business and advancing our path toward sustainable profitability.” – Luc Mongeau, CEO, Canopy Growth.
  • “We’re proud to join Canopy Growth and begin this next phase as one team.” – Richard Clément, Co‑Founder & former Chief Cultivation Officer, MTL Cannabis.

All amounts are expressed in Canadian dollars.

Read the original news release →

More from CANOPY GROWTH CORPORATION J